Berman Capital Advisors’s DexCom DXCM Stock Holding History

Berman Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$509K	Buy	3,728 +1,780	+91%	+$224K	0.08%	131
2021 Q2	$206K	Buy	1,948 +1,324	+212%	+$127K	0.03%	228
2021 Q1	$56K	Buy	624 +36	+6%	+$3.38K	0.01%	439
2020 Q4	$53K	Sell	588 -204	-26%	-$18.2K	0.01%	399
2020 Q3	$81K	Buy	792 +228	+40%	+$23.8K	0.02%	256
2020 Q2	$57K	Buy	564 +36	+7%	+$3.22K	0.02%	302
2020 Q1	$35K	Buy	528 +136	+35%	+$8.46K	0.01%	360
2019 Q4	$21K	Sell	392 -40	-9%	-$1.9K	0.01%	517
2019 Q3	$16K	Buy	432 +92	+27%	+$3.57K	0.01%	566
2019 Q2	$12K	Buy	340 +36	+12%	+$1.13K	﹤0.01%	664
2019 Q1	$9K	Buy	304 +116	+62%	+$4.08K	﹤0.01%	683
2018 Q4	$5K	Buy	+188	New	+$5.96K	﹤0.01%	677

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berman Capital Advisors's DXCM Position: Q3 2021 in Review

Berman Capital Advisors increased its DexCom (DXCM) stake by 91% in Q3 2021, buying an estimated $224K and bringing the position to 3,728 shares worth $509K. The position accounts for 0.08% of the portfolio, ranked #131.

Berman Capital Advisors first reported a position in DXCM in Q4 2018 and has held it in 12 quarters since. 796 funds tracked by Wall St. Rank hold DXCM as of Q3 2021.

Berman Capital Advisors held 3,728 shares of DexCom worth $509K as of Q3 2021.
Berman Capital Advisors bought 1,780 DexCom shares in Q3 2021, an estimated $224K.
DexCom made up 0.08% of Berman Capital Advisors's portfolio in Q3 2021, its #131 holding.
Berman Capital Advisors first reported a position in DexCom in Q4 2018 and has held it in 12 quarters since.
796 funds tracked by Wall St. Rank held DexCom as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.